12:00 AM
Aug 13, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Ganetespib: Phase II started

Synta began the open-label, international Phase II CHIARA trial to evaluate 200 mg/m 2 IV ganetespib given on days 1, 8 and 15 of a 28-day cycle in...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >